News Blog

Από τις 31 Μαρτίου θα ξεκινήσει η καταβολή της επιστροφής κεφαλαίου ύψους 0,85 ευρώ ανά μετοχή για τους μετόχους της Ελλάκτωρ, όπως αποφάσισε η Έκτακτη Γενική Συνέλευση των μετόχων

«Δημιουργούμε ένα νέο όμιλο με δύναμη και συνέργειες από την κατασκευή. Αλλά δεν μας ενδιαφέρουν μόνο η κατασκευή, οι ΑΠΕ, τα ακίνητα. Δίνουμε βάρος στις παραχωρήσεις και θα ανακοινώσουμε σύντομα λεπτομέρειες», ήταν το μήνυμα που χτες εξέπεμψε, μεταξύ άλλων, ο διευθύνων σύμβουλος του ομίλου AKTOR.

Την άδεια από τη Ρυθμιστική Αρχή ενέργειας της Ρουμανίας, έλαβε η Metlen για να δραστηριοποιηθεί στις αγορές ηλεκτρικής ενέργειας στη Ρουμανία, και ειδικότερα στην αγορά προμήθειας ηλεκτρικής ενέργειας.

Στη διάθεση ποσοστού 15,9% του μετοχικού κεφαλαίου της Trade Estates προχώρησε η Fourlis. Μια συναλλαγή που ολοκληρώθηκε χθες μέσα από 34 «πακέτα» που αντιστοιχούν σε 19,2 εκατ. μετοχές της εταιρείας, συνολικής αξίας 28,9 εκατ. ευρώ.

President Donald Trump on Monday ordered the Treasury and Commerce Departments to create a U.S. sovereign-wealth fund—a first for the nation.

Spirits maker Diageo said Tuesday that it is taking steps to deal with the potential impact of U.S. tariffs on key supply chain regions and has removed its medium-term guidance due to macroeconomic and geopolitical uncertainty.

Walgreens Boots Alliance will suspend its quarterly dividend, citing its need for cash amid ongoing litigation and turnaround efforts.

Luxury sports car maker Ferrari said on Tuesday its revenue and core earnings would rise by at least 5% this year, supported by strong product delivery and demand for personal touches to its vehicles, having met targets for 2024.

Archer-Daniels-Midland Co. said it will reduce its work force as the company expects profits to decline for a third straight year.

Salvatore Ferragamo shares plunged after the Italian luxury-goods company said it was parting ways with its chief executive before the end of his mandate, after a year marked by slowing sales as the industry grappled with sluggish demand for luxury goods.

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong fourth-quarter profit on sales of cancer drug Keytruda.

Palantir Technologies Inc. shares jumped after the company gave a full-year revenue forecast that exceeded analysts’ estimates, thanks to what Chief Executive Officer Alex Karp described as “untamed organic growth” in demand for its artificial intelligence software.

Vodafone Group shares fell after the company reported a sharp revenue decline in Germany, its biggest market, reflecting the impact from a TV law change in the country and a more competitive environment.

PepsiCo forecast annual profit below expectations and missed quarterly revenue estimates on Tuesday, as the Doritos maker faces weakening demand for its sodas and snacks such as Lay’s in the United States, its largest market.

Spotify reported its first ever full year of profitability, fueled by record user growth and austerity measures after years of heavy spending on growth initiatives such as podcasts.

Estée Lauder Cos. said it plans to eliminate between 5,800 to 7,000 positions in a corporate restructuring meant to return the flagging company to sales growth under its new chief executive officer.

PayPal shares fell 5% in premarket trading on Tuesday after the digital payments giant’s operating margin shrank in the fourth quarter, raising concerns over the possibility of a sluggish recovery and overshadowing a strong profit forecast for 2025.

Intesa Sanpaolo announced a 2 billion euro ($2.07 billion) buyback and raised its 2025 net income outlook after its fourth-quarter operating profit significantly outpaced expectations.

UBS shares lost ground after the lender’s fourth-quarter results and up to $3 billion share buyback plans failed to impress.

Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a smaller-than-feared drop in sales of its COVID-19 vaccine.